Transcutaneous Bilirubinometer Market Size, Growth & Trends by 2034

Transcutaneous Bilirubinometer Market Size and Forecasts (2021–2034), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Type (Benchtop and Portable); End User (Hospitals, Research Laboratories and Clinics); and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00040710
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : May 26, 2026
Transcutaneous Bilirubinometer Market Size, Growth & Trends by 2034
Report Date: May 26, 2026   |   Report Code: TIPRE00040710 Email: sales@theinsightpartners.com

2025 Market Size

US$ 539.13 Mn

Base year value

2034 Forecast

US$ 1,032.89 Mn

Projected by 2034

CAGR 2026-2034

8.47 %

Growth rate

Addressable Market

US$ 7,447.50 Mn

(2026-2034)

The Transcutaneous Bilirubinometer Market size is expected to reach US$ 1,032.89 Million by 2034 from US$ 539.13 Million in 2025. The market is estimated to record a CAGR of 8.47% from 2026 to 2034.

The report is segmented by Type (Benchtop and Portable), End User (Hospitals, Research Laboratories and Clinics)

Purpose of the Report

The report Transcutaneous Bilirubinometer Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Transcutaneous Bilirubinometer Market Segmentation Type

  1. Benchtop and Portable

End User

  1. Hospitals
  2. Research Laboratories and Clinics

Market Assessment and Insights

  • Global market for Transcutaneous Bilirubinometer was valued at US$ 539.13 Million in 2025
  • Annual market size is expected to reach US$ 1,032.89 Million by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 7,447.50 Million
  • Market is anticipated to register a CAGR of 8.47% during the forecast period
  • The United States represents a key market, supported by Rising Incidence of Neonatal Jaundice, Non-invasive and Painless Diagnosis, Advancements in Healthcare Infrastructure, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Expansion into Emerging Markets, Home Healthcare Market Growth, Integration with Telemedicine Solutions are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Philips Healthcare, Natus Medical, Radiometer Medical, Medtronic, Konica Minolta, HemoCue, Dräger Medical, Mennen Medical, Bilirubin Technologies, BiliCare, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Transcutaneous Bilirubinometer Market: Strategic Insights

transcutaneous-bilirubinometer-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Transcutaneous Bilirubinometer Market Growth Drivers

  1. Rising Incidence of Neonatal Jaundice: The increasing prevalence of neonatal jaundice, a common condition in newborns, is a major driver for the transcutaneous bilirubinometer market. This condition, which causes high bilirubin levels leading to jaundice, requires monitoring for early diagnosis and treatment. Transcutaneous bilirubinometers offer a non-invasive, effective solution for monitoring bilirubin levels in newborns, fueling market growth.
  2. Non-invasive and Painless Diagnosis: The demand for non-invasive and painless diagnostic tools is driving the growth of the transcutaneous bilirubinometer market. Traditional methods, like blood tests, are often uncomfortable and time-consuming. In contrast, transcutaneous bilirubinometry allows for quick, pain-free measurements of bilirubin levels, making it highly preferred in pediatric care, particularly for newborns and infants.
  3. Advancements in Healthcare Infrastructure: Improving healthcare infrastructure, particularly in developing regions, is contributing to the market’s expansion. As hospitals and healthcare centers adopt more advanced and accurate diagnostic tools, transcutaneous bilirubinometers are being increasingly used. These devices are easier to operate and more cost-effective than traditional blood tests, making them a popular choice in both developed and emerging markets.

Transcutaneous Bilirubinometer Market Future Trends

  1. Portable and Handheld Devices:
    There is a growing trend towards portable and handheld transcutaneous bilirubinometers. These devices are designed for convenience, enabling healthcare providers to perform quick and accurate bilirubin tests at the point of care. The portability and ease of use are particularly beneficial in neonatal units, emergency departments, and home healthcare settings, contributing to their increased adoption.
  2. Integration with Digital Platforms:
    The integration of transcutaneous bilirubinometers with digital platforms is becoming a significant trend. These devices are now capable of storing data and connecting with electronic health records (EHRs). The data integration facilitates better tracking of bilirubin levels over time and enhances patient management, enabling healthcare professionals to make informed decisions and improve clinical outcomes.
  3. Advances in Sensor Technology:
    Recent advancements in sensor technology have significantly enhanced the accuracy and reliability of transcutaneous bilirubinometers. Newer models use sophisticated sensors that provide more precise bilirubin measurements with minimal error. These innovations are driving the adoption of transcutaneous bilirubinometers in both clinical and homecare settings, making them a preferred choice for neonatal care.

Transcutaneous Bilirubinometer Market Opportunities

  1. Expansion into Emerging Markets:
    There is a growing opportunity to introduce transcutaneous bilirubinometers in emerging markets where the incidence of neonatal jaundice is high, and the need for affordable diagnostic tools is critical. The rising healthcare investments and increasing awareness about neonatal care in these regions present significant growth potential for transcutaneous bilirubinometer manufacturers.
  2. Home Healthcare Market Growth:
    The home healthcare market presents a promising opportunity for transcutaneous bilirubinometers. With an increasing number of parents seeking ways to monitor their newborns' health at home, the demand for easy-to-use, non-invasive medical devices is rising. Transcutaneous bilirubinometers could serve this need by enabling parents to track bilirubin levels conveniently, reducing the need for frequent hospital visits.
  3. Integration with Telemedicine Solutions:
    The growing trend of telemedicine presents an opportunity for transcutaneous bilirubinometers. By integrating these devices with telemedicine platforms, healthcare providers can remotely monitor bilirubin levels in neonates. This can be particularly beneficial for rural or underserved areas, offering timely diagnosis and intervention without requiring in-person visits to healthcare facilities.

Transcutaneous Bilirubinometer Market Report Scope

Report Attribute Details
Market size in 2025 US$ 539.13 Million
Market Size by 2034 US$ 1,032.89 Million
Global CAGR (2026 - 2034) 8.47%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Type
  • Benchtop and Portable
By End User
  • Hospitals
  • Research Laboratories and Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Philips Healthcare
  • Natus Medical
  • Radiometer Medical
  • Medtronic
  • Konica Minolta
  • HemoCue
  • Dräger Medical
  • Mennen Medical
  • Bilirubin Technologies
  • BiliCare

Transcutaneous Bilirubinometer Market Players Density: Understanding Its Impact on Business Dynamics

The Transcutaneous Bilirubinometer Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

transcutaneous-bilirubinometer-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Transcutaneous Bilirubinometer Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Transcutaneous Bilirubinometer Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

The main drivers include the rising incidence of neonatal jaundice, the growing demand for non-invasive and painless diagnostic methods, and advancements in healthcare infrastructure that increase the adoption of such diagnostic tools.

The trend towards portable and handheld devices enhances the accessibility and convenience of bilirubin testing, allowing healthcare providers to perform quick and accurate tests at the point of care, which is driving greater adoption in various healthcare settings.

Integration with digital platforms allows transcutaneous bilirubinometers to store and share data, enhancing patient management. This data connectivity improves clinical decision-making, making it easier to track bilirubin levels over time and improving overall patient outcomes.

Advancements in sensor technology have significantly improved the accuracy and reliability of transcutaneous bilirubinometers. More sophisticated sensors allow for more precise bilirubin measurements, which enhance the effectiveness of the devices in neonatal care.

Emerging markets present significant opportunities due to the high incidence of neonatal jaundice and the need for affordable diagnostic tools. With growing healthcare investments and improving healthcare infrastructure, there is a substantial market potential for these devices in these regions.

Integration with telemedicine platforms allows remote monitoring of bilirubin levels, providing timely care for newborns, especially in rural or underserved areas. This telehealth solution can improve diagnosis, reduce hospital visits, and enhance patient outcomes, further expanding the market for transcutaneous bilirubinometers.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA